Stock Market & Financial Investment News

News Breaks March 7, 2013 07:16 EDT SRPT Sarepta: Coming FDA talks will determine fastest path toward eteplirsen approval The company said, "We look forward to our upcoming meetings with the FDA to discuss our eteplirsen data and to determine the fastest path toward potential approval, along with our plans to supply the market in the event of an early approval." The company said additional drugs for Duchenne Muscular Dystrophy, or DMD, continue to progress through preclinical development. News For SRPT From The Last 14 Days Check below for free stories on SRPT the last two weeks. Sign up for a free trial to see the rest of the stories you've been missing. June 17, 2013 12:20 EDT SRPT Options with increasing implied volatility: WLT LNCO SRPT LINE Subscribe for More Information June 14, 2013 11:23 EDT SRPT Options with increasing implied volatility: TWO SRPT LNCO LINE DVA 06:15 EDT SRPT Leerink remains cautious on accelerated approval for Sarepta Subscribe for More Information June 5, 2013 13:29 EDT SRPT Options with decreasing implied volatility: INFI SRPT GES SUPN CPRT Subscribe for More Information Sign up for a free trial to see the rest of the stories you've been missing.